Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
Clinical trial NCT05882513 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05882513
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2025-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.